Emerging treatment strategies for glioblastoma multiforme

Glioblastoma multiforme (GBM) is the deadliest form of brain tumor with a more than 90% 5-year mortality. GBM has a paltry median survival of 12.6 months attributed to the unique treatment limitations such as the high average age of onset, tumor location, and poor current understandings of the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlsson, Steven K, Brothers, Shaun P, Wahlestedt, Claes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237465/
https://www.ncbi.nlm.nih.gov/pubmed/25312641
http://dx.doi.org/10.15252/emmm.201302627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237465/
https://www.ncbi.nlm.nih.gov/pubmed/25312641
http://dx.doi.org/10.15252/emmm.201302627

Ejemplares similares